Our data are also supporting the notion that preexisting AE36 immunity might be beneficial through induction of antigen specific CD4+ T cells, with cytotoxic function, that could successfully recognize tumor cells with down-regulated HLA class I alleles. The gene discussed is CD4; the disease is neoplasm.